These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 38751227)

  • 1. Bivalent and bitopic ligands of the opioid receptors: The prospects of a dual approach.
    Hovah ME; Holzgrabe U
    Med Res Rev; 2024 May; ():. PubMed ID: 38751227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computational Advances for the Development of Allosteric Modulators and Bitopic Ligands in G Protein-Coupled Receptors.
    Feng Z; Hu G; Ma S; Xie XQ
    AAPS J; 2015 Sep; 17(5):1080-95. PubMed ID: 25940084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bridging the gap: bitopic ligands of G-protein-coupled receptors.
    Lane JR; Sexton PM; Christopoulos A
    Trends Pharmacol Sci; 2013 Jan; 34(1):59-66. PubMed ID: 23177916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent Advances in the Drug Discovery and Development of Dualsteric/ Bitopic Activators of G Protein-Coupled Receptors.
    Reinecke BA; Wang H; Zhang Y
    Curr Top Med Chem; 2019; 19(26):2378-2392. PubMed ID: 31833462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The best of both worlds? Bitopic orthosteric/allosteric ligands of g protein-coupled receptors.
    Valant C; Robert Lane J; Sexton PM; Christopoulos A
    Annu Rev Pharmacol Toxicol; 2012; 52():153-78. PubMed ID: 21910627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, Synthesis, and Biological Activity of New CB2 Receptor Ligands: from Orthosteric and Allosteric Modulators to Dualsteric/Bitopic Ligands.
    Gado F; Ferrisi R; Polini B; Mohamed KA; Ricardi C; Lucarini E; Carpi S; Domenichini F; Stevenson LA; Rapposelli S; Saccomanni G; Nieri P; Ortore G; Pertwee RG; Ghelardini C; Di Cesare Mannelli L; Chiellini G; Laprairie RB; Manera C
    J Med Chem; 2022 Jul; 65(14):9918-9938. PubMed ID: 35849804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bitopic Ligands and Metastable Binding Sites: Opportunities for G Protein-Coupled Receptor (GPCR) Medicinal Chemistry.
    Fronik P; Gaiser BI; Sejer Pedersen D
    J Med Chem; 2017 May; 60(10):4126-4134. PubMed ID: 28140580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opioid Ligands Addressing Unconventional Binding Sites and More Than One Opioid Receptor Subtype.
    Drakopoulos A; Moianos D; Prifti GM; Zoidis G; Decker M
    ChemMedChem; 2022 Jul; 17(14):e202200169. PubMed ID: 35560796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Impact of the Secondary Binding Pocket on the Pharmacology of Class A GPCRs.
    Egyed A; Kiss DJ; Keserű GM
    Front Pharmacol; 2022; 13():847788. PubMed ID: 35355719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Orthosteric/allosteric bitopic ligands: going hybrid at GPCRs.
    Valant C; Sexton PM; Christopoulos A
    Mol Interv; 2009 Jun; 9(3):125-35. PubMed ID: 19592673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular alliance-from orthosteric and allosteric ligands to dualsteric/bitopic agonists at G protein coupled receptors.
    Mohr K; Schmitz J; Schrage R; Tränkle C; Holzgrabe U
    Angew Chem Int Ed Engl; 2013 Jan; 52(2):508-16. PubMed ID: 23225228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computational insights into the molecular mechanisms of differentiated allosteric modulation at the mu opioid receptor by structurally similar bitopic modulators.
    Wang H; Reinecke BA; Zhang Y
    J Comput Aided Mol Des; 2020 Aug; 34(8):879-895. PubMed ID: 32193867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine D2 Receptors Dimers: How can we Pharmacologically Target Them?
    Carli M; Kolachalam S; Aringhieri S; Rossi M; Giovannini L; Maggio R; Scarselli M
    Curr Neuropharmacol; 2018 Jan; 16(2):222-230. PubMed ID: 28521704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Designing drugs and chemical probes with the dualsteric approach.
    Zha J; He J; Wu C; Zhang M; Liu X; Zhang J
    Chem Soc Rev; 2023 Dec; 52(24):8651-8677. PubMed ID: 37990599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Avidity and positive allosteric modulation/cooperativity act hand in hand to increase the residence time of bivalent receptor ligands.
    Vauquelin G; Bricca G; Van Liefde I
    Fundam Clin Pharmacol; 2014 Oct; 28(5):530-43. PubMed ID: 24118041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New Insights into Bitopic Orthosteric/Allosteric Ligands of Cannabinoid Receptor Type 2.
    Ferrisi R; Polini B; Ricardi C; Gado F; Mohamed KA; Baron G; Faiella S; Poli G; Rapposelli S; Saccomanni G; Aldini G; Chiellini G; Laprairie RB; Manera C; Ortore G
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-based design of bitopic ligands for the µ-opioid receptor.
    Faouzi A; Wang H; Zaidi SA; DiBerto JF; Che T; Qu Q; Robertson MJ; Madasu MK; El Daibani A; Varga BR; Zhang T; Ruiz C; Liu S; Xu J; Appourchaux K; Slocum ST; Eans SO; Cameron MD; Al-Hasani R; Pan YX; Roth BL; McLaughlin JP; Skiniotis G; Katritch V; Kobilka BK; Majumdar S
    Nature; 2023 Jan; 613(7945):767-774. PubMed ID: 36450356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanobody-Mediated Dualsteric Engagement of the Angiotensin Receptor Broadens Biased Ligand Pharmacology.
    Braga Emidio N; Small BM; Keller AR; Cheloha RW; Wingler LM
    Mol Pharmacol; 2024 Feb; 105(3):260-271. PubMed ID: 38164609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure of the dopamine D3 receptor bound to a bitopic agonist reveals a new specificity site in an expanded allosteric pocket.
    Arroyo-Urea S; Nazarova AL; Carrión-Antolí Á; Bonifazi A; Battiti FO; Lam JH; Newman AH; Katritch V; García-Nafría J
    Res Sq; 2023 Dec; ():. PubMed ID: 38196573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dualsteric muscarinic antagonists--orthosteric binding pose controls allosteric subtype selectivity.
    Schmitz J; van der Mey D; Bermudez M; Klöckner J; Schrage R; Kostenis E; Tränkle C; Wolber G; Mohr K; Holzgrabe U
    J Med Chem; 2014 Aug; 57(15):6739-50. PubMed ID: 25051097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.